ONCE MONTHLY EMGALITY (GALCANEZUMAB-GNLM) 120 MG INJECTION Trademark

Trademark Overview

On Monday, August 31, 2020, a trademark application was filed for ONCE MONTHLY EMGALITY (GALCANEZUMAB-GNLM) 120 MG INJECTION with the United States Patent and Trademark Office. The USPTO has given the ONCE MONTHLY EMGALITY (GALCANEZUMAB-GNLM) 120 MG INJECTION trademark a serial number of 90148406. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 1, 2024. This trademark is owned by Eli Lilly and Company. The ONCE MONTHLY EMGALITY (GALCANEZUMAB-GNLM) 120 MG INJECTION trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Providing medical information
once monthly emgality (galcanezumab-gnlm) 120 mg injection

General Information

Serial Number90148406
Word MarkONCE MONTHLY EMGALITY (GALCANEZUMAB-GNLM) 120 MG INJECTION
Filing DateMonday, August 31, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 30, 2021

Trademark Statements

Description of MarkThe mark consists of a motion mark, namely, a loose cluster of green, blue, red, and yellow dots that float from the upper left-hand corner, above the word "EMGALITY" in green, and exit the upper right-hand corner. Above the wording "EMGALITY" is the green wording "once monthly". Below "EMGALITY" is the black wording (galcanezumab-gnlm) 120 mg injection. The background of the mark is white, and is not claimed as a feature of the mark.
Pseudo MarkONCE MONTHLY EMGALITY (GALCANEZUMAB-GNLM) ONE HUNDRED TWENTY MILOGRAM INJECTION; ONCE MONTHLY EMGALITY (GALCANEZUMAB-GNLM) ONE TWO ZERO
Indication of Colors claimedThe color(s) black, green, blue, red, and yellow is/are claimed as a feature of the mark.
Goods and ServicesProviding medical information
NOT AVAILABLE"ONCE MONTHLY, 120 MG INJECTION, OR GALCANEZUMAB-GNLM"

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 6, 2020
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285
Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events

Event DateEvent Description
Thursday, September 3, 2020NEW APPLICATION ENTERED
Tuesday, October 6, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 7, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, November 4, 2020ASSIGNED TO EXAMINER
Tuesday, November 3, 2020ASSIGNED TO EXAMINER
Wednesday, November 4, 2020ASSIGNED TO EXAMINER
Friday, December 4, 2020NON-FINAL ACTION WRITTEN
Friday, December 4, 2020NON-FINAL ACTION E-MAILED
Friday, December 4, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 26, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 26, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 26, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 27, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 25, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 10, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 30, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 30, 2021PUBLISHED FOR OPPOSITION
Tuesday, November 23, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, November 23, 2021SOU EXTENSION 1 FILED
Tuesday, November 23, 2021SOU EXTENSION 1 GRANTED
Thursday, November 25, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 11, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, May 11, 2022SOU EXTENSION 2 GRANTED
Tuesday, May 25, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, May 11, 2022SOU EXTENSION 2 FILED
Friday, May 13, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 8, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, November 8, 2022SOU EXTENSION 3 FILED
Tuesday, November 8, 2022SOU EXTENSION 3 GRANTED
Thursday, November 10, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 10, 2023SOU EXTENSION 4 FILED
Wednesday, May 10, 2023SOU EXTENSION 4 GRANTED
Friday, May 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 9, 2023SOU TEAS EXTENSION RECEIVED
Thursday, November 9, 2023SOU EXTENSION 5 FILED
Thursday, November 16, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, November 16, 2023SOU EXTENSION 5 GRANTED
Friday, November 17, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 1, 2024ABANDONMENT - NO USE STATEMENT FILED
Friday, July 12, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Wednesday, May 10, 2023SOU TEAS EXTENSION RECEIVED

Related Keywords

gnlm injection galcanezumab emgality monthly once information medical providing